Mylor Bio Shines at TPE 2025: Pioneering New Heights in E-Liquid Technology

Feb.13.2025
From January 29th to 31st, one of the world’s largest tobacco and e-cigarette trade shows, the Total Product Expo (TPE), took place in Las Vegas. Mylor bio Co.,Ltd (hereafter referred to as “Mylor Bio”) made its mark at the event, showcasing its FUNC series nicotine salts and flavor modification technologies, offering groundbreaking solutions to push the boundaries of e-cigarette technology.

[2Firsts Reporting from Las Vegas] From January 29th to 31st, one of the world’s largest tobacco and e-cigarette trade shows, the Total Product Expo (TPE), took place in Las Vegas. As a platform for technological innovation in the e-cigarette industry, TPE gathers global brands, distributors, and experts, serving as a crucial venue for product launches and technical discussions. Mylor bio Co.,Ltd (hereafter referred to as “Mylor Bio”) made its mark at the event, showcasing its FUNC series nicotine salts and flavor modification technologies, offering groundbreaking solutions to push the boundaries of e-cigarette technology.

 

About Mylor Bio:

 

Mylor bio Co.,Ltd., a global leader in the development and manufacturing of e-liquid products, was founded in 2019. With state-of-the-art automated production lines and stringent quality control systems, Mylor Bio has rapidly established itself as an industry benchmark. The company operates a modern 5,000 square meter manufacturing facility, achieving an automation rate of 80%. Well-equipped with cutting-edge analysis instruments, such as GC, GC-MS, HPLC, and ICP-MS.With the support of a professional R&D team consisting of over ten experienced flavorists, Mylor Bio has successfully developed over 30,000 e-liquid formulas. The products are exported to key global markets including Europe, North America, the Middle East, Southeast Asia, and Russia.

 

Mylor Bio Shines at TPE 2025: Pioneering New Heights in E-Liquid Technology
Mylor Bio Certification | Image Source: Mylor Bio

 

In the future, Mylor Bio will become an innovative pioneer in the industry through continuous technological advancements and an open collaboration approach, with a more forward-thinking vision and scientific practices.

 

FUNC Series Nicotine Salts: Precision Sensory Delivery  and Personalized Experience

 

Nicotine is the primary active ingredient in e-cigarettes, with the majority of it remaining in the aerosol as nicotine salts.. Nicotine salts are smoother and less harsh, allowing for a higher inhalable nicotine concentration.


Mylor Bio, drawing on years of customer service experience and market research, has recognized the diverse demands of different consumer groups regarding the sensation of nicotine. Leveraging the release patterns and absorption mechanisms of nicotine, Mylor Bio has innovatively launched the FUNC series nicotine salts to meet diverse needs.

 

Mylor Bio Shines at TPE 2025: Pioneering New Heights in E-Liquid Technology
FUNC Series Nicotine Salts Product at TPE Booth

 

Mylor Bio Shines at TPE 2025: Pioneering New Heights in E-Liquid Technology
FUNC Series Nicotine Salts Product at TPE Booth

 

FUNC Series Nicotine Salts Features:

 

· Precise Sensory Delivery: The FUNC series nicotine salts are designed to precisely target the head, throat, and chest areas, addressing a variety of preferences for headrush, throat hit, and chest kick sensations.

· Variety of Options: Including H-nicotine salt, T-nicotine salt, and C-nicotine salt.

 

Mylor Bio Shines at TPE 2025: Pioneering New Heights in E-Liquid Technology
Diagram showing the partitioned effects of FUNC series nicotine salts | Image Source: Mylor Bio

 

Mylor Bio Shines at TPE 2025: Pioneering New Heights in E-Liquid Technology
Sensory characteristics comparison between three nicotine salts and nicotine benzoate | Image Source: Mylor Bio

 

Compared to nicotine benzoate, H-nicotine salt's headrush intensity and onset speed increased by 43% and 25%, respectively; T-nicotine salt's throat hit improved by 43%; C-nicotine salt's chest kick increased by 67%.

 

Mylor Bio Shines at TPE 2025: Pioneering New Heights in E-Liquid Technology
Comparison of market appeal between three nicotine salts and nicotine benzoate | Image Source: Mylor Bio

 

Compared to nicotine benzoate, the consumer liking for H-nicotine salt, T-nicotine salt, and C-nicotine salt increased by 42%, 25%, and 46%, respectively. The willingness to use again increased by 66%, 25%, and 33%.

 

Flavor Modification Solutions: Improving E-Liquid Flavor Profile

 

Beyond nicotine salts, flavor profile is another key factor in consumer choice of e-cigarettes. At TPE, Mylor Bio showcased its flavor modifiers, including:

· Sweeteners: Enhancing the natural sweetness, customized for ceramic core devices.

· Acidulants: Maximizing the freshness of fruit flavors.

· Cooling Agents: Precisely regulating the cooling effect’s target areas.

· Humectants: Enhancing hydration sensation and smoothness

 

Mylor Bio: Reshaping the Future of the Industry through Technological Innovation

 

At this year’s TPE, Mylor Bio’s booth attracted many international buyers. Ms. Lin, Sales Manager of Mylor Bio, shared:
“During this exhibition, we presented our latest nicotine salt series products, which received high recognition from industry professionals. We have already reached initial cooperation intentions with several globally renowned brands.”

 

Mylor Bio Shines at TPE 2025: Pioneering New Heights in E-Liquid Technology
Visitors at the TPE exhibition show interest in Mylor Bio’s nicotine salt technology

 

Mylor Bio Shines at TPE 2025: Pioneering New Heights in E-Liquid Technology
Visitors at the TPE exhibition show interest in Mylor Bio’s nicotine salt technology

 

John, an e-cigarette brand owner from the United States, expressed, “Mylor Bio's nicotine salt technology is indeed impressive. The innovations in taste are refreshing, especially the precise nicotine delivery technology combined with multiple flavor modification solutions which have broken new ground in flavor details. This multi-layered sensory experience is exactly what the market needs.”

 

 

As Regulators Focus on Nicotine Pouch Child Safety, Safeguard Pursues an External Packaging Route
As Regulators Focus on Nicotine Pouch Child Safety, Safeguard Pursues an External Packaging Route
As regulators pay closer attention to child safety in nicotine pouches, manufacturers face a practical challenge: how to strengthen child-resistant packaging without unnecessarily reworking products, production lines and regulatory submissions already in place. In a written interview with 2Firsts, Chemular detailed Safeguard’s external packaging approach, its customer-specific testing requirements and possible PMTA pathways. The model remains early-stage, but it offers a new way to think about an increasingly important regulatory and manufacturing issue.
Industry Insight
Sep.19
Ireland Raises Nicotine Product Taxes Again as Cigarettes Gain €1 and Vape Duty Is Set to Jump 40%
Ireland Raises Nicotine Product Taxes Again as Cigarettes Gain €1 and Vape Duty Is Set to Jump 40%
Ireland has increased tobacco excise under Budget 2027 and announced a further rise in its E-liquid Products Tax. From Oct. 7, the tax burden on a pack of 20 cigarettes in the most popular price category increased by €1, with pro-rata increases on other tobacco products. The government plans to raise EPT from €0.50 to €0.70 per millilitre from Jan. 1, 2027, a 40% increase applying to both nicotine-containing and nicotine-free e-liquids. The tobacco duty increase is expected to raise about €63.1 million in a full year.
Regulations
Oct.09
NAS 2026 | Former FDA Tobacco Chief Mitch Zeller Calls for Shift From “End Game” to “End State”
NAS 2026 | Former FDA Tobacco Chief Mitch Zeller Calls for Shift From “End Game” to “End State”
At the 2026 New Approaches Summit in New York, former FDA Center for Tobacco Products Director Mitch Zeller called for the tobacco harm reduction debate to shift from the traditional “end game” toward defining a desired “end state.” He also highlighted unresolved concerns around dual use, argued that biomarkers of exposure may be more meaningful than cigarettes-per-day in assessing risk reduction, and said nicotine misperceptions remain a major barrier to public health progress.
Sep.25
South Korea's Tobacco Plan Excludes 6-Methyl Nicotine as Customs Tightens Import Controls and Analog Liquid Imports Fall 83%
South Korea's Tobacco Plan Excludes 6-Methyl Nicotine as Customs Tightens Import Controls and Analog Liquid Imports Fall 83%
South Korea's government unveiled its first Tobacco Harm Management Basic Plan for 2027–2031 on October 29, 2026, proposing broader testing of vaping and heated tobacco products while excluding nicotine analogs such as 6-methyl nicotine. Synthetic nicotine came under tobacco regulation on April 24, and a June investigation found 6-methyl nicotine in 12 liquid inhalation products marketed as nicotine-free. Customs data released in September showed that imports of nicotine analog solutions fell 83.3%, from 12 metric tons in January–April to 2 metric tons in May–August. By September 20, imports had reached approximately 15 metric tons for the year, with 99.99% originating from China. Customs authorities have tightened pre-clearance testing and supply-chain documentation requirements, while the MFDS expects to complete its assessment of nicotine analog hazards by the end of 2026.
Regulations
Nov.04
JTI Liggett Puts U.S. Value Cigarette Brands in Spotlight at 2026 NACS Show
JTI Liggett Puts U.S. Value Cigarette Brands in Spotlight at 2026 NACS Show
At the 2026 NACS Show in Las Vegas, JTI Liggett highlighted its value-priced cigarette portfolio, including LD and Montego, following JT Group's acquisition of Vector Group. The company's U.S. business reported market share gains, with LD sales volume rising 32.6% in the first half of 2026. Meanwhile, Ploom was displayed separately at Altria's booth under an existing partnership. JTI Liggett booth staff told 2Firsts that the company had not yet launched nicotine pouch products in the United States.
EXPO
Oct.09
FDA Unifies Tobacco Registration and Product Listing Form Across Product Categories
FDA Unifies Tobacco Registration and Product Listing Form Across Product Categories
The U.S. FDA has consolidated two tobacco establishment registration and product listing forms into a redesigned Form FDA 3741 covering all regulated product categories, including e-cigarettes, heated tobacco products and nicotine pouches. The current requirements remain limited to domestic establishments. Separately, the FDA has proposed extending registration and product listing requirements to foreign manufacturers, signaling greater regulatory attention to manufacturing entities and product-level information across the tobacco and nicotine supply chain.
FDA
Sep.30